Name: Botulinum neurotoxin type A resistance: An emerging problem
Description: Long-term use and high doses of BoNT-A may lead to immunoresistance, limiting its future therapeutic benefit.

Botulinum neurotoxin type A resistance: An emerging problem

Written by

Botulinum neurotoxin A (BoNT-A), often referred to as ‘Botox’, is commonly used to treat medical conditions and increasingly in cosmetic procedures. However, long-term use and high doses of BoNT-A may lead to immunoresistance, limiting its future therapeutic benefit. A panel of experts including Dr Mary Dingley, Cosmetic Medicine Centre, Australia, is addressing this emerging issue. Its published recommendations offer a […]

Lateral flow test detects SARS-CoV-2 neutralising antibodies

Written by

Novodiax Inc., under the guidance of Dr Jianfu Wang, has produced a novel lateral flow device called CoNAb. The device detects neutralising antibodies (NAbs) against SARS-CoV-2 (the virus responsible for COVID-19). Measuring NAbs is important to help us determine whether vaccination programmes are effective by measuring the level of immunity of vaccine recipients. They are also a vital tool for […]